NAFLD patients displayed a trend towards higher plasma DPP4 concentration than no-NAFLD, although this difference did not reach the statistical significance (448.5 ± 103.2 ng/ml vs. 341.4 ± 128.4 ng/ml, p = 0.06). Here, DPP4 is linked to metabolic dysfunction-associated steatotic liver disease.